ACHILLION PHARMACEUTICALS INC SEC Filings

Filed On	Filing
16 Feb 2021	SEC SCHEDULE 13G
14 Feb 2020	SC 13G
14 Feb 2020	SC 13G/A
12 Feb 2020	SCHEDULE 13G/A
12 Feb 2020	SCHEDULE 13G/A
10 Feb 2020	SC 13G/A
07 Feb 2020	15-12B
31 Jan 2020	EFFECT
31 Jan 2020	EFFECT
31 Jan 2020	EFFECT
31 Jan 2020	EFFECT
30 Jan 2020	Form 4: G1 Execution SERVICES, Llc, 10% owner and 2 others Disposed of 14,126,415 shares (Other Transaction) ($89M)
30 Jan 2020	Form 3: G1 Execution SERVICES, Llc, 10% owner and 2 others Holds 10,917 shares of Common Stock
29 Jan 2020	Form 4: Vitullo Nicole, Director Returned 3,454,972 shares to the issuer ($21.8M) · Disposed of 272,000 Stock Option (Right to Buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Zelenkofske Steven, EVP, Chief Medical Officer Disposed of 700,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Verwiel Frank, Director Disposed of 132,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Van Nostrand Robert L, Director Returned 40,000 shares to the issuer ($252K) · Disposed of 227,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Truitt Joseph, Director Returned 3,500 shares to the issuer ($22.1K) · Disposed of 2,892,766 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Scheer David, Director Returned 92,764 shares to the issuer ($584K) · Disposed of 227,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Manning Martha E, General Counsel Returned 2,500 shares to the issuer ($15.8K) · Disposed of 365,000 Stock Options (Right to buy) (Disposition to Issuer) · Disposed of 245,000 Stock Options (Right to buy) (Disposition to Issuer)

Comments